Akero Therapeutics

Last updated: October 10, 2024

Andrew Cheng, CEO
Andrew Cheng, CEO
USA | Funding: $951.1M (+)

Website: https://akerotx.com/

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.